Engineering precursor metabolite pools for increasing production of antitumor mithramycins in Streptomyces argillaceus.
Metab Eng
; 20: 187-97, 2013 Nov.
Article
en En
| MEDLINE
| ID: mdl-24148183
ABSTRACT
Mithramycin (MTM) is a polyketide antitumor compound produced by Streptomyces argillaceus constituted by a tricyclic aglycone with two aliphatic side chains, a trisaccharide and a disaccharide chain. The biosynthesis of the polyketide aglycone is initiated by the condensation of ten malonyl-CoA units to render a carbon chain that is modified to a tetracyclic intermediate and sequentially glycosylated by five deoxysugars originated from glucose-1-phosphate. Further oxidation and reduction render the final compound. We aimed to increase the precursor supply of malonyl-CoA and/or glucose-1-phosphate in S. argillaceus to enhance MTM production. We have shown that by overexpressing either the S. coelicolor phosphoglucomutase gene pgm or the acetyl-CoA carboxylase ovmGIH genes from the oviedomycin biosynthesis gene cluster in S. argillaceus, we were able to increase the intracellular pool of glucose-1-phosphate and malonyl-CoA, respectively. Moreover, we have cloned the S. argillaceus ADP-glucose pyrophosphorylase gene glgCa and the acyl-CoAdiacylglycerol acyltransferase gene aftAa, and we showed that by inactivating them, an increase of the intracellular concentration of glucose-1-phosphate/glucose-6-phosphate and malonyl-CoA/acetyl-CoA was observed, respectively. Each individual modification resulted in an enhancement of MTM production but the highest production level was obtained by combining all strategies together. In addition, some of these strategies were successfully applied to increase production of four MTM derivatives with improved pharmacological properties demycarosyl-mithramycin, demycarosyl-3D-ß-D-digitoxosyl-mithramycin, mithramycin SK and mithramycin SDK.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Streptomyces
/
Plicamicina
/
Ingeniería Metabólica
/
Glucofosfatos
/
Malonil Coenzima A
/
Antibióticos Antineoplásicos
Idioma:
En
Revista:
Metab Eng
Asunto de la revista:
ENGENHARIA BIOMEDICA
/
METABOLISMO
Año:
2013
Tipo del documento:
Article
País de afiliación:
España